Dengue virus hijacks a noncanonical oxidoreductase function of a cellular oligosaccharyltransferase complex [preprint]
Authors
Lin, David L.Cherepanova, Natalia A.
Bozzacco, Leonia
MacDonald, Margaret R.
Gilmore, Reid
Tai, Andrew W.
UMass Chan Affiliations
Department of Biochemistry and Molecular PharmacologyDocument Type
PreprintPublication Date
2017-06-01Keywords
microbiologyDengue virus
CRISPR
STT3B
MAGT1
oligosaccharyltransferase
Amino Acids, Peptides, and Proteins
Cells
Enzymes and Coenzymes
Genetic Phenomena
Virology
Virus Diseases
Viruses
Metadata
Show full item recordAbstract
Dengue virus (DENV) is the most common arboviral infection globally, infecting an estimated 390 million people each year. We employed a genome-wide CRISPR screen to identify host dependency factors required for DENV propagation, and identified the oligosaccharyltransferase (OST) complex as an essential host factor for DENV infection. Mammalian cells express two OSTs containing either STT3A or STT3B. We found that the canonical catalytic function of the OSTs as oligosaccharyltransferases is not necessary for DENV infection, as cells expressing catalytically inactive STT3A or STT3B are able to support DENV propagation. However, the OST subunit MAGT1, which associates with STT3B, is also required for DENV propagation. MAGT1 expression requires STT3B, and a catalytically inactive STT3B also rescues MAGT1 expression, supporting the hypothesis that STT3B serves to stabilize MAGT1 in the context of DENV infection. We found that the oxidoreductase CxxC active site motif of MAGT1 was necessary for DENV propagation as cells expressing an AxxA MAGT1 mutant were unable to support DENV infection. Interestingly, cells expressing single-cysteine CxxA or AxxC mutants of MAGT1 were able to support DENV propagation. Utilizing the engineered peroxidase APEX2, we demonstrate the close proximity between MAGT1 and NS1 or NS4B during DENV infection. These results reveal that the oxidoreductase activity of the STT3B-containing OST is necessary for DENV infection, which may guide the development of antivirals targeting DENV.Source
bioRxiv 130914; doi: https://doi.org/10.1101/130914. Link to preprint on bioRxiv service.
DOI
10.1101/130914Permanent Link to this Item
http://hdl.handle.net/20.500.14038/29320Related Resources
Now published in mBio doi: 10.1128/mBio.00939-17.
Rights
The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It is made available under a CC-BY 4.0 International license.Distribution License
http://creativecommons.org/licenses/by/4.0/ae974a485f413a2113503eed53cd6c53
10.1101/130914
Scopus Count
Collections
Except where otherwise noted, this item's license is described as The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It is made available under a CC-BY 4.0 International license.